LINK WILLIAM J PHD 4

What Happened
William J. Link, Ph.D., an Outside Director of RxSight, was granted 37,037 restricted stock units (RSUs) on June 17, 2026 (transaction code A — award/grant). The filing reports no per-share price or immediate dollar value. Each RSU represents a contingent right to receive one share of RxSight common stock upon vesting. Per the award terms, 100% of the RSUs vest on the earlier of (i) the one-year anniversary of the grant (June 17, 2027) or (ii) the date of the next annual meeting of stockholders, provided Link continues as an Outside Director.

Key Details

• Transaction date: 2026-06-17; Form 4 filed: 2026-06-18 (timely).
• Award: 37,037 RSUs; conversion: 1 RSU = 1 common share; no price or total value reported.
• Vesting: 100% vests on earlier of one-year anniversary or next annual meeting, contingent on continued service as an Outside Director (see F1–F2).
• Shares owned after transaction: Not specified in the filing.
• Footnote: Shares held by Link Family Enterprise, L.P.; Link is a managing partner and may share voting/investment power but disclaims beneficial ownership except for pecuniary interest (F3).
• Filing includes Exhibit 24 (Power of Attorney).

Context
RSUs are compensation awards that only become actual shares when they vest; this grant is a standard director compensation action rather than an open-market buy or sale. Because the units are service‑conditioned, the grant does not immediately change Link’s tradable share position and should be viewed as a retention/compensation event, not a direct endorsement or sale of the stock.